JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
51 hedge funds and large institutions have $25.5M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
Holders
51
Holding in Top 10
–
Calls
$162K
Puts
$179K
Top Buyers
| 1 | +$513K | |
| 2 | +$310K | |
| 3 | +$269K | |
| 4 |
EGA
Eagle Global Advisors
Houston,
Texas
|
+$241K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$175K |
Top Sellers
| 1 | -$669K | |
| 2 | -$428K | |
| 3 | -$331K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$291K |
| 5 |
Morgan Stanley
New York
|
-$202K |